While A. muciniphila-derived EVs (AmEVs) have shown promise in ameliorating colitis through Toll-like receptor 2 (TLR2) signaling suppression and mucosal repair, their potential to mitigate colitis-associated cognitive deficits remains unexplored.12 This evidence concerns the gene TLR2 and Cognitive impairment.